Search

everythingexperts & clinicslearnresearchcommunity

for

Search:↓

Menopause reduces skin collagen and elasticity, and while estrogen therapy can help, its risks require careful consideration.

Chlormadinone acetate is a strong, well-tolerated hormone used in birth control and hormone therapy with benefits for menstrual pain and skin conditions.

Certain genetic variations are linked to increased androgen levels in PCOS, but more research is needed to understand these connections fully.

The document concludes that proper diagnosis and tailored long-term treatment can effectively manage androgenic disorders in women, improving patient care outcomes.

Oxidative stress, not insulin resistance, is significantly related to free androgen index in PCOS.

Some skin diseases and their treatments can negatively affect male fertility.

Higher DHT in male baldness may protect against prostate cancer.

Hormonal therapies are safe and effective for treating acne in female adolescents, with specific treatments for those with endocrine disorders.

Acne is a common skin condition linked to diet, hormones, and genetics, and early treatment can prevent scarring.

Fetuin A levels are higher in PCOS patients, while asprosin levels show no difference.

Salivary cytokines and the Free Androgen Index are promising non-invasive markers for diagnosing PCOS.

Flutamide caused damage to male rat reproductive organs and may affect fertility.

Some cancer and immune system drugs can cause serious side effects, including heart, lung, nerve, and organ damage, which need careful monitoring and management.

Menstrual disorders are common in adolescents and can be influenced by weight, activity, and health issues, requiring careful evaluation and more research for effective treatment.

New treatments for excessive hair growth in women include insulin modulators and enzyme inhibitors.

Nutrease powder, a high-protein, low-carb supplement, can help manage Polycystic Ovary Syndrome symptoms, regulate periods, improve ovulation, and restore fertility.

Women with PCOS are at high risk of glucose metabolism issues and heart diseases, especially if overweight, highlighting the need for early intervention.

Hirsutism, excessive hair growth in women, is often caused by PCOS and can be managed with medication and personalized treatment plans.

The European Society of Endocrinology advises individualized long-term management for PCOS, focusing on lifestyle changes, accurate diagnosis, and treatments for associated health risks and symptoms.

The conclusion is that oral contraceptives and antiandrogens can treat hirsutism and acne in women with cutaneous hyperandrogenism, but more research is needed for effective treatments, especially for hair loss.

Oral spironolactone's effectiveness for adult female acne is not well-supported by strong evidence.

Hormonal treatments, including birth control and antiandrogens, can effectively treat acne in women.

PCOS is a long-term condition that needs more research for better understanding and treatment.

Endocrinological evaluation is crucial for properly diagnosing and treating acne.

Most women with excess male hormones have Polycystic Ovary Syndrome, and hormonal therapy can improve symptoms but may cause side effects.

Women with PCOS have overall higher body fat, not abnormal fat placement, and more insulin resistance.

Hirsutism in women is often due to hormone sensitivity and has significant psychological effects.

The document concludes that effectively managing PCOS requires a multifaceted approach.

The bulletin provides guidelines for diagnosing and managing PCOS, suggesting weight loss, hormonal contraceptives, and diabetes screening, with clomiphene for infertility and various treatments for excess hair.

Skin changes can help diagnose and manage endocrine disorders like thyroid problems, diabetes, and adrenal gland conditions.